Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells

8 Jul 2014

Abstract excerpt

// Yue-Zhi Lee 1,* , Cheng-Wei Yang 1,* , Hsin-Yu Chang 1,* , Hsing-Yu Hsu 1,* , Ih-Shen Chen 2 , Hsun-Shuo Chang 2 , Chih-Hao Lee 3 , Jinq-chyi Lee 1 , Chidambaram Ramesh Kumar 1 , Ya-Qi Qiu 1,4 , Yu-Sheng Chao 1 and Shiow-Ju Lee 1 1 Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan 2 School of Pharmacy, College of Pharmacy, Kaohsiung Medical University,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cancer, Hypoxia, and Metabolism
Share to Polyamine Metabolism and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25026281
DOI: 10.18632/oncotarget.2173

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cellsPMID 25026281Read ↗

A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.Semantic proximity Read ↗

Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2Semantic proximity Read ↗

Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.Semantic proximity Read ↗

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic CancerSemantic proximity Read ↗

Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.Semantic proximity Read ↗

A pan-cancer analysis of the glutaminase and their association with prognosis, tumor microenvironment, and therapeutic targetsSemantic proximity Read ↗

Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.Semantic proximity Read ↗

A novel allosteric site employs a conserved inhibition mechanism in human kidney-type glutaminase.Semantic proximity Read ↗

Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinomaSemantic proximity Read ↗

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.Semantic proximity Read ↗

Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.Semantic proximity Read ↗

Inhibiting Glutamine Metabolism Blocks Coronavirus Replication in Mammalian CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.